换一批Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.
第一作者：
Dilek,Dincol
第一单位：
Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. dincol@medicine.ankara.edu.tr
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);综合疗法(Combined Modality Therapy);环磷酰胺(Cyclophosphamide);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);依托泊甙(Etoposide);女(雌)性(Female);发热(Fever);随访研究(Follow-Up Studies);人类(Humans);异环磷酰胺(Ifosfamide);Kaplan-Meiers评估(Kaplan-Meier Estimate);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);美司钠(Mesna);中年人(Middle Aged);米托蒽醌(Mitoxantrone);周围神经系统疾病(Peripheral Nervous System Diseases);泼尼松龙(Prednisolone);前瞻性研究(Prospective Studies);放射疗法, 辅助(Radiotherapy, Adjuvant);缓解诱导(Remission Induction);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1007/s12032-009-9313-x
PMID
19787462
发布时间
2021-10-20
- 浏览39
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
